Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Tolerability of Brivaracetam as Adjunctive Treatment in Pediatric Epilepsy
NCT04715646Phase 3Recruiting
- Sponsor
- UCB
- Start
- Mar 2021
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by UCB. Started Mar 2021; status: recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04715646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715646.